Lv3
370 积分 2024-10-21 加入
A Novel Scoring System Based on Oxford Classification Indicating Steroid Therapy Use for IgA Nephropathy
12天前
已完结
Targeted-release budesonide versus systemic corticosteroids in IgA nephropathy: a real-world comparative study
25天前
已完结
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
26天前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
26天前
已完结
Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis
26天前
已完结
IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment
26天前
已完结
Significance of KM55 immunohistochemical staining in the diagnosis and prognosis of IgA nephropathy
26天前
已完结
Pathogenic Immunoglobulin A-Producing Cells in Immunoglobulin A Nephropathy
26天前
已完结
Diagnostic and prognostic value of galactose-deficient IgA1 in patients with IgA nephropathy: an updated systematic review with meta-analysis
26天前
已完结
皖公网安备34019202002308
